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We conducted the first molecular study of tuberculosis
(TB) to estimate the role of household contact and trans-
mission from HIV-positive putative source contacts (PSCs)
in a high HIV-prevalence area. TB patients in a long-term
population-based study in Malawi were asked about past
contact with TB. DNA fingerprinting was used to define
clusters of cases with identical strains. Among 143 epi-
demiologically defined PSC-case pairs, fingerprinting con-
firmed transmission for 44% of household and family
contacts and 18% of other contacts. Transmission was less
likely to be confirmed if the PSC were HIV positive than if
he or she were HIV negative (odds ratio 0.32, 95% confi-
dence interval [CI] 0.14–0.74). Overall, epidemiologic links
were found for 11% of 754 fingerprint-clustered cases. We
estimate that 9%–13% of TB cases were attributable to
recent transmission from identifiable close contacts and
that nearly half of the TB cases arising from recent infection
had acquired the infection from HIV-positive patients.
T
he HIV epidemic has dramatically increased tubercu-
losis (TB) incidence. The magnitude of this effect
depends in part on the relative infectiousness of HIV-
infected TB patients: they are less likely to have smear-
positive disease and may be infectious for a shorter period
than other patients since they have higher death rates and
may seek health care earlier (1). Several studies have
found that household contacts of HIV-positive patients had
lower rates of Mycobacterium tuberculosis infection than
those of HIV-negative patients, even after adjusting for
sputum smear status of the cases and HIV status of the
contacts (2–4), though other studies have found no differ-
ences in infection rates (5–7). 
DNA fingerprinting can be used to identify clusters of
TB patients that share M. tuberculosis strains with identical
patterns and to estimate when transmission occurred. To
date, DNA fingerprinting studies comparing transmission
from HIV-positive and HIV-negative patients have been
small, and the differences have not been significant (8,9).
Studies can investigate sources of M. tuberculosis
infection by seeking epidemiologic links within finger-
print-defined clusters or by comparing the DNA finger-
prints of epidemiologically linked persons (8–10). In this
study, we combine these 2 approaches to analyze the only
long-term population-based molecular epidemiologic
study of TB in an area with a high prevalence of HIV.
Novel methods were used to estimate the proportion of TB
in the population that is attributable to transmission from
known contacts and from HIV-positive patients. 
Methods
Since 1986, as part of the Karonga Prevention Study in
northern Malawi, patients in whom TB was suspected have
been identified by using enhanced passive surveillance.
Project staff are based at peripheral clinics and the district
hospital to examine anyone with chronic cough or enlarged
lymph nodes. Patients in whom TB is suspected are also
identified in the course of other studies, including house-
hold visits to TB patients, although in practice most patients
come to the clinic or hospital. Sputum is taken for smear
microscopic examination and culture, and material from
lymph node biopsy specimens, ascites, and pleural fluid is
also cultured when available (11). DNA fingerprinting has
been carried out on cultures from all TB patients since late
1995 (12). Cultures that macroscopically resemble M.
tuberculosis  are sent to the Health Protection Agency
Mycobacterium Reference Laboratory, London, United
Kingdom, for species identification and drug sensitivity
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using IS6110 restriction fragment length polymorphism
(RFLP), following standard procedures (13). Spoligotyping
(14) is performed on strains with <5 bands on the RFLP
pattern. Treatment follows Malawi National TB Control
Programme guidelines. TB patients were tested for HIV
after counseling and if consent was given. No antiretroviral
treatment was available at the time of the study (11).
Since 1997, at the time of diagnosis, all TB patients
have been asked about persons they knew who had had
TB, either in their family or household (at any time) or
among other acquaintances (in the last 5 years) (15).
Details gathered on these putative source contacts (PSCs)
allowed them to be identified within the project database:
≈90% of named PSCs who were said to have had TB in
the district within the previous 5 years were confirmed as
having been treated for TB. In addition, all persons seen
in the district during long-standing epidemiologic studies
are asked about their current and past residences and their
parents, allowing genetic linkages and household histories
to be constructed. PSCs identified only from the epidemi-
ologic database were included in this study if they were
first-degree relatives or half siblings of the patient or if
they were documented as having lived in the same house-
hold as the patient at the time that the PSC had TB.
DNA fingerprints of cultures from all case-PSC pairs
were compared by computer (Gelcompar 4.1, Applied
Maths, Kortrijk, Belgium) and checked visually (12).
Transmission was “confirmed” if the pair had identical
strains, or if the RFLPpatterns differed by 1 to 4 bands and
the later strain was the first or only example of the new
pattern in the dataset (12,16). Since >1 PSC was identified
for some patients, the analysis was repeated excluding
PSCs with smear-negative results or extrapulmonary dis-
ease, and, if  >1 PSC was smear-positive, choosing the
most likely source of the infection by selecting the most
closely matched strains and the closest contacts (e.g., con-
tacts within the household were considered closer than
nonhousehold contacts). We have previously explored
RFLP pattern evolution among the first 80 such pairs with
smear-positive PSCs (to 2001) (12). Here, in a larger
dataset, we explored risk factors associated with a named
PSC being the confirmed source of transmission and esti-
mate the proportion of TB in the population attributable to
contact with a smear-positive household or other close
family member and the relative contribution of HIV-posi-
tive and HIV-negative patients to transmission.
In addition, we estimated the proportion of RFLP-
defined links that can be explained epidemiologically.
Strains were defined as clustered if the RFLP pattern was
shared by >2 patients. The proportion of patients in RFLP-
defined clusters for whom epidemiologic links were
known was calculated, and any variation with cluster size
or band number was investigated. Assuming 1 index case
per cluster, we calculated the proportion of secondary
cases within clusters for which an epidemiologically
linked source could be identified (17). 
Statistical Analysis
Comparison of proportions used χ2 tests, or exact tests
when numbers were small. Odds ratios were calculated by
using logistic regression. To calculate the proportion of
cases in the population attributable to different types of
contact (the population attributable fraction [PAF]), we
adapted the formula PAF = p′(RR-1)/RR where p′ is the
prevalence of the exposure (history of contact) in the
cases, and RR is the relative risk of TB in those who are
exposed compared to those who are not exposed (18). The
expression (RR-1)/RR is algebraically equivalent to the
risk difference percent, (r1–r0)/r1, where r1 is the risk in the
exposed, and r0 is the risk in the unexposed. We do not
know RR, r1,or r0, but the risk difference percent is equiv-
alent to the proportion of epidemiologically linked cases
for which transmission from a PSC is confirmed (since this
represents the proportion of cases in the exposed group
that were caused by the exposure). PAF is thus calculated
as the proportion of case-PSC pairs for which transmission
was confirmed, multiplied by the prevalence of exposure
(having a PSC) among the cases. To estimate the contribu-
tion of HIV-positive patients to onward transmission, we
adjusted the relative probabilities of transmission being
confirmed from HIV-positive and HIV-negative PSCs, by
the proportion of smear-positive TB patients in the popula-
tion who were HIV positive.
Ethics permission
Permission for the study was received from the Malawi
National Health Sciences Research Committee and the
ethics committee of the London School of Hygiene and
Tropical Medicine. 
Results
From late 1995 to early 2003, a total of 1,248 culture-
positive TB patients were identified in Karonga District.
Successful RFLP fingerprints were available on 1,194 iso-
lates from 1,044 patients. After excluding 25 fingerprints
because laboratory error was suspected (12), 1,029
patients had RFLP results: 74% were clustered (19). The
isolates from 81 persons had <5 bands, and spoligotypes
were available on 64 of these. HIV results were available
for 61%, of whom 65% were positive.
Transmission Confirmation in 
Epidemiologically Defined Case-PSC Pairs
Fingerprints were available for 200 case-PSC pairs, of
whom 51 had identical strains and 8 more had similar
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between the 2 persons (Table 1). Transmission was no
more likely to be confirmed if the information came from
the patient’s history only or from the epidemiologic data-
base only, but was more likely if the information came
from both sources (p = 0.05). Transmission was more like-
ly if PSCs had smear-positive TB than if they had smear-
negative or extrapulmonary TB (p = 0.06). Of the 7 pairs
with confirmed matches and RFLPpatterns with <5 bands,
spoligotypes for both members of the pair were available
for 3; they were identical for 2, and different for the third
(a strain with 4 bands). The pair with different spoligo-
types and a pair with similar but not identical RFLP pat-
terns, with 1 band for the PSC and 4 bands for the patient
(and missing spoligotypes), were excluded from further
analyses.
When only smear-positive PSCs were used and the
most likely source of transmission was selected, RFLP
confirmation of transmission was much more likely for
household and family PSCs (44%) than for other PSCs
(friends, neighbors or colleagues, 18%, Table 2). Trans-
mission was confirmed for 8 (62%) of 13 spouse pairs, and
for 12 (48%) of 25 persons who nursed the sick patient or
shared a sleeping dwelling with them. Transmission was
less likely to be confirmed from male than from female
PSCs, and less likely from HIV-positive PSCs than from
HIV-negative PSCs (Table 2). The effect of sex of the PSC
(odds ratio [OR] 0.39, 95% confidence interval [CI]
0.19–0.81) was reduced by adjusting for closeness of con-
tact (OR 0.46, 95% CI 0.21–0.99) and was no longer sig-
nificant after adjusting for HIV status of the PSC (OR
0.56, 95% CI 0.25–1.2). The effects of closeness and of
HIV status of the PSC became slightly stronger when each
factor was adjusted for: adjusted OR 4.6 (1.7–12.3) for
family contacts and 4.1 (1.6–10.4) for household contacts,
compared to other contacts; adjusted OR 0.32 (0.14–0.74)
for HIV-positive contacts compared to HIV-negative con-
tacts. These results were not altered by adjusting for degree
of smear positivity of PSCs or for the other factors shown
in Table 2. The results were similar if all index cases with
<5 bands were excluded.
To estimate the origin of the infection in those for
whom transmission from identified, PSCs was not con-
firmed, cases were classified as likely to be due to reacti-
vation if the strain was the first or only example in the
dataset and as recent infection if the strain was part of an
existing cluster. For the patients without confirmed trans-
mission from their PSCs, 33% had first/unique strains. In
the whole dataset, the proportion of persons with
first/unique strains was 39%, or 33% after excluding the
first 2 years, in which first examples are more likely.
Proportion of TB Cases Due to Recognized 
Close Contact with a Smear-positive Patient
Of the 1,029 TB patients included in the study, 219
(21.3%) had at least 1 named family or household PSC with
recorded smear-positive tuberculosis, and 86 other patients
reported a PSC who was not identified in the database who
may have had smear-positive disease. Overall, 177 (17.2%)
of the patients had at least 1 PSC outside the family or
household. Other patients either had no PSCs or none with
smear-positive disease. Taking the proportion with trans-
mission confirmed from family and household PSCs com-
bined as 44.3% (Table 2) and the prevalence of exposure (at
least 1 family or household PSC with smear-positive TB) as
21.3%, we estimate that 0.443 × 0.213 = 9% of TB case-
patients in this population were attributable to recent trans-
mission from identified smear-positive PSCs in their
families or households. If the 86 additional PSCs are
included, the estimate rises to 13%. Similarly, we estimate
a PAF of 3.1% (0.182 × 0.172) for recent transmission from
identified PSCs outside the family and household.
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from HIV-positive Patients
HIV-negative PSCs were twice as likely as HIV-posi-
tive PSCs to be confirmed by RFLPas sources of infection
(46% vs. 24%), and this was seen both within the family
and household (64% vs. 32%) and outside (23% vs. 12%).
Overall, 61% of smear-positive TB patients were HIV pos-
itive. If we assume that the pattern of transmission from
contacts is representative of the relative transmission from
HIV-positive and HIV-negative patients in other settings,
45% of M. tuberculosis infections in this community are
transmitted from HIV-positive patients: (0.61 × 0.24)/
[(0.61 × 0.24) + ([1–0.61] × 0.46)].
Investigation of Clusters
Cluster sizes ranged from 2 to 37. The proportion of
patients with clustered strains for whom epidemiologic
links were identified is shown in Table 3. This proportion
was no higher for strains with high band numbers than for
those with <5 bands and did not vary consistently with
cluster size. If we assume 1 index case per cluster, 623 of
the 754 clustered cases were secondary. Of the 84 cases
with epidemiologic links within RFLP-defined clusters, 52
were secondary, so sources of infection were identified for
8.3% (52/623) of secondary cases within clusters.
Conclusion
In Africa, case finding for TB is generally passive.
Although being a household contact of a TB patient is a
strong risk factor, in Africa as elsewhere (15,20), in high-
incidence settings, most cases of TB are not attributable to
household contact. This finding has been demonstrated in
traditional epidemiologic studies (21) and more recently by
using molecular techniques (22). The apparent importance
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many people exposed to a small risk can account for more
disease than a few exposed to a large risk (23).
DNA fingerprinting allows direct measurement of the
proportion of cases with known exposure who acquired TB
from that exposure. This proportion has varied from 95%
in the Netherlands (10), 70% in San Francisco (8) and 71%
elsewhere in the United States (9), to <50% in Cape Town,
South Africa (24), and in our study. The studies varied in
whether they included smear-negative PSCs, in the way
contact was defined, and in whether similar but not identi-
cal RFLP patterns were included. Smear-negative PSCs
were associated with a lower likelihood of confirmed
transmission in our study and in the United States (9).
Workplace contacts in the United States (9) and contacts
outside the family and household in our study were much
less likely to be confirmed as sources of infection. The
inclusion of similar RFLP patterns that are the first exam-
ple of their type will increase the proportion of confirmed
transmissions, though with an increased risk of false attri-
butions of the source of infection. Even identical strains
may have other origins, particularly if the strain is com-
mon. On the other hand, actual transmission may not be
recognized if different strains are seen in the PSC and case
because of cross-contamination or other laboratory error or
because the infection in the PSC was a mixture of strains. 
This analysis, like all analyses to date of M. tuberculo-
sis  transmission based upon IS6110 RFLP patterns, is
based on the assumption that multiple infections are infre-
quent and thus that a single RFLP-defined strain reflects
the infection status of a patient. A recent study from South
Africa has hinted that multiple infections may be more fre-
quent than previously assumed (25). If this is the case, then
we (and all previous RFLP-based studies) have underesti-
mated the proportions of transmission occurring within
households. This assumption should not affect our esti-
mates of relative transmission from HIV-positive and HIV-
negative patients.
A lower proportion of confirmed transmission from
identifiable PSCs is expected in high-incidence settings.
As the incidence of TB decreases in a population, patients
are increasingly concentrated in high-risk groups with par-
ticular risk factors for disease. Close contacts of patients
may share many risk factors. As the risk of a close contact
of a TB patient having had TB increases relative to the risk
of a casual contact having had TB, the proportion of TB
due to transmission from a close contact will also increase.
In our study, 44% of patients with a smear-positive PSC in
their household within the previous few years appear to
have acquired their infection from that person. The source
of the infections in persons without confirmed transmis-
sion is unknown, but two thirds of patients were part of
existing clusters so the infections probably were recently
acquired locally.
In Cape Town, the proportion of identifiable household
contacts with confirmed transmission was similarly low
(24). In that study, the proportion of TB in the community
attributable to transmission within the household (from
smear-positive or smear-negative contacts) was estimated
at 19%. In our study, by using different methods, we esti-
mated that 9%–13% of TB cases were attributable to trans-
mission from smear-positive PSCs within the household or
close family, and 3% from other named sources. The low
proportion of cases with identified sources of infection is
corroborated by conventional epidemiologic studies in this
and other populations (15,21).
The low proportion of TB attributable to identifiable
links is also supported by the similarly low proportion of
persons in clusters who can be linked epidemiologically,
both in our study and studies in South Africa (22) and India
(26). In our study, the epidemiologic links were established
independently of the molecular data; further links might
have been found by detailed investigations of particular
clusters (10), but many of these more-difficult-to-define
links represent casual contact. Identifiable links have been
found for a higher proportion of clustered patients in low-
incidence settings (10,27,28), but, excluding the casual
links, the proportion is still <50%.
One reason for the particularly low proportion of con-
firmed transmission in our study is the high prevalence of
HIV and the effect of HIV on transmission. Our study is
the first to demonstrate lower infectiousness of HIV-infect-
ed TB patients by DNA fingerprinting of epidemiological-
ly linked case-contact pairs. The lower rate of transmission
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Although HIV status was not available for all patients, this
factor should not bias this estimate.
Extrapolating the results from case-PSC pairs to the
community assumes similar relative transmission patterns,
but is reasonable since HIV-positive patients had similarly
reduced transmission within families and households and
outside them. The lower infectiousness of HIV-positive
patients does not mean that they have a minor role in TB
transmission, since nearly two thirds of TB patients are
HIV positive. It does, however, help limit the extent of the
HIV-related increase in TB in the population (1,11,29).
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